Company Filing History:
Years Active: 1987
Title: Innovations of Hans Joss in Coronary Therapeutics
Introduction
Hans Joss is an accomplished inventor based in Murgenthal, Switzerland. He has made significant contributions to the field of coronary therapeutics, particularly through his innovative approach to drug formulation. His work focuses on improving the delivery and efficacy of therapeutic agents.
Latest Patents
One of Hans Joss's notable patents is for a coronary therapeutic agent in the form of soft gelatin capsules. This invention addresses previous challenges related to capsule size and the low concentration of the active substance, nifedipine. By utilizing PVP and dissolving nifedipine in THFP, Joss has developed a formulation that allows for a capsule weight of only 162 mg, enhancing the therapeutic potential of nifedipine.
Career Highlights
Hans Joss has been associated with Siegfried Aktiengesellschaft, a company known for its commitment to pharmaceutical innovation. His work has not only contributed to the company's portfolio but has also advanced the field of coronary therapy.
Collaborations
Throughout his career, Hans Joss has collaborated with notable colleagues, including Stephan Dvorsky and Franz Radivojevich. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hans Joss's contributions to coronary therapeutics exemplify the impact of innovative thinking in the pharmaceutical industry. His patent for a soft gelatin capsule formulation represents a significant advancement in drug delivery systems.